INTRODUCTION
Epigenetics is the term used to describe heritable changes in gene function that occur without a change in the DNA sequence. The predominant epigenetic modification of DNA in mammalian genomes is the methylation of cytosine (5-MeC), which does not alter the function of the gene product, but provides information as to where and when the gene should be expressed. The primary target sequence of methylation in the DNA of mammals is at 5¢-CpG-3¢ dinucleotides. However, not all CpG dinucleotides in normal mammalian cells are methylated; in fact, CpG sites in CpG island promoter regions are protected from DNA methylation, whereas CpG sites in gene-coding or non-coding regions are commonly methylated. Genome-wide DNA methylation patterns are established in early development and are then essentially maintained during differentiation, with only some modulation in DNA methylation patterns spanning tissue-specific promoters 1 . However, genomic DNA methylation patterns can be disrupted in disease, in particular in cancer cells, in which aberrant methylation of CpG island promoters is associated with gene silencing and demethylation is associated with gene activation 2 . To understand further the biology that promotes methylation changes in normal development, and that is influenced by diet, environment and heredity to modify DNA methylation patterns in disease, requires accurate and reproducible methods to analyze and quantify the DNA methylation sequence in detail.
A number of methods for determining the distribution of 5-MeC in DNA have been described (reviewed in refs. [3] [4] [5] . These can be divided into three broad groups: differential enzymatic cleavage of DNA; selective chemical cleavage of DNA; and differential sensitivity to chemical conversion. The detection of 5-MeC using sodium bisulphite to chemically convert the DNA prior to DNA sequencing was first reported by Frommer et al. in 1992 (ref. 6) and was optimised by Clark et al. in 1994 (ref. 7) . Since that time, bisulphite genomic sequencing has become the standard for DNA methylation analysis, as this method defines the methylation state of every cytosine residue in the target sequence, at single-molecule resolution. The key to the bisulphite protocol for determining DNA methylation is based on the selective chemical reaction of sodium bisulphite with cytosine versus 5-MeC residues. The reaction is highly single-strand specific and cannot be performed on doublestranded DNA. A summary of the bisulphite genomic conversion and PCR amplification protocol is outlined in Figure 1 . The deamination of cytosine by sodium bisulphite and subsequent PCR involves five critical steps: denaturation of the DNA into single strands; reaction of bisulphite with the 5-6 double bond of cytosine to give a cytosine sulphonate derivative; hydrolytic deamination of the resulting cytosine-bisulphite derivative to give a uracil sulphonate derivative; removal of the sulphonate group by a subsequent alkali treatment to give uracil; and PCR amplification. Because the conversion of cytosines to uracils creates noncomplementary strands (i.e., uracils opposite guanines), DNA must be amplified with separate pairs of primers that are specific for either the top or bottom DNA strands. Following PCR amplification, the uracils are amplified as thymines, whereas 5-MeC residues are amplified as cytosines. To determine methylation at single-nucleotide resolution, the PCR amplicon can either be sequenced directly or cloned and sequenced (Fig. 2) . DNA methylation in the PCR target region is then read by scoring the remaining cytosine resides in the sequence.
The majority of new data on DNA methylation is now based on prior treatment of the DNA with bisulphite, followed by DNA amplification with target specific primers. However, the method of analysis of the amplified PCR fragments can vary considerably depending on the degree of specificity and detail of methylation required. Some of the different analysis options that have been described for post-PCR analyses after bisulphite treatment are summarized in Tables 1 and 2 . The various post-bisulphite analysis options can be divided into either 'Non-selective Detection' for quantitative methylation analysis ( Table 1) or 'Selective Detection' for analysis of only methylated DNA or only unmethylated DNA ( Table 2) . Bisulphite genomic clonal sequencing analysis is still the only method that can give resolution at every cytosine site in the target sequence at the single-molecule level; other analytical procedures are less detailed, but can give either a semi-quantitative or an average estimate of the methylation state of the amplified target sequence.
It is now clear, with the completion of the human genome sequence, that re-sequencing the genome for DNA methylation is necessary to fully understand the complexity and function of DNA methylation in different normal and diseased cell types. The need for such detailed analysis is gaining momentum and is enabled by bisulphite methylation sequencing in a large project termed the Human Epigenome Project [8] [9] [10] [11] [12] [13] [14] . Here, we present the 'gold-standard' bisulphite genomic conversion protocol that can be used for sequencing every cytosine residue in a target were bisulphite-treated in triplicate, according to either the single tube or 96-well plate procedures, and the bisulphite-treated DNA was resuspended in 50 ml after each reaction. A total of 2 ml from each 50 ml bisulphite-treated DNA was used in a 20 ml single-round PCR, also in triplicate. This converts to an equivalent of 40 ng, 4 ng, 400 pg, 40 pg or 0 pg starting genomic DNA in each of nine replicate PCRs (3 bisulphites Â 3 PCR amplifications) for each of the different clean-up procedures, respectively. (b) The graph plots the percentage of successful PCR amplifications from the nine replicates. Essentially, all protocols provided efficient bisulphite conversion and recovery for 1,000 ng and 100 ng of starting DNA and were able to robustly amplify DNA after the different clean-up and desulphonation steps, for both single tube and 96-well reactions. However, when the starting DNA is limiting (10 ng) -that is, when only the equivalent of 400 pg of bisulphite-treated DNA is used for PCR -the number of successful PCRs is reduced by about 50%. The PCR becomes even more stochastic when only 1 ng DNA is treated, and 40 pg is used in the reaction with only 1-2 PCRs out of 9 giving a product. It is clear that having more DNA (4-40 ng) in the PCR reaction results in robust PCR amplification; however, if DNA is limiting, multiple PCR reactions are necessary to ensure successful amplification and representative sampling 18 . In summary, in the single tube reactions, the Microcon performs slightly better with a greater yield of DNA for a more robust PCR amplification. DNAs purified by Qiagen size and Qiagen Affinity are essentially equivalent in PCR amplification efficiency after bisulphite treatment, and both procedures also compare favorably to single tube reactions. Figure 1 | Schematic diagram of the five critical steps in the bisulphite conversion and PCR amplification reaction. An example DNA sequence, 5¢ to 3¢ orientation, with the complementary top (a) and bottom (b) DNA strands is shown. The CpG sites are colored red and methylation of a CpG site is indicated by m CpG. After denaturation, the DNA is single stranded and each strand, a and b, can be amplified independently with strand-specific bisulphite-specific primers to determine the methylation state of each strand. Example strandspecific and bisulphite-specific PCR primers are indicated above and below the DNA strands (in reality, primers are longer; see text). In the forward primers, the cytosine residues are replaced by thymine residues and, in the reverse primers, the guanines (opposite cytosine residues) are replaced by adenine residues. Detailed design parameters of the bisulphite-specific PCR primers are given in the text. After PCR amplification, methylation of the CpG sties in the target sequence can be determined by either direct PCR sequencing of the product or cloning and sequencing (for example results, see 40 Recently adapted for higher-throughput multiplexing SNuPE-IP RP HPLC (v) Application of ion-pair reverse-pair HPLC to analysis of SNuPE products of DNA degradation and PCR will provide an estimate of amplifiable DNA prior to the bisulphite reaction. Pretreatment of DNA To efficiently denature DNA, it can be advantageous to reduce the size of high-molecular-weight DNA. The fragment size of the DNA that is to be bisulphite-converted needs to be no larger than 2 kb to aid denaturation to single DNA strands. DNA isolated from fixed tissue samples is normally of low molecular weight after isolation and therefore can be added directly into the bisulphite reaction. DNA that is of high molecular weight can be fragmented prior to use by either digestion with a six-base restriction enzyme, such as EcoRI or HindIII, or sonication in DNA buffer at 50-75% power on ice for 2 min, or shearing the DNA, in DNA buffer, by passing the solution five times through a 26 G needle. Sonication or shearing the DNA is less precise but allows the amplification of all target sequences, whereas restriction enzyme digestion is predictive but limits the amplification to known PCR targets. Gently mix all reagents, centrifuge for 10 sec and incubate at 55 1C in a water bath with a lid, for 4-16 h. m CRITICAL STEP It is important to prepare the Saturated Sodium Metabisulfite at pH 5.0 freshly, by dissolving 7.6 g Na 2 O 5 S 2 in 15 ml sterile H 2 O, and adding 464 ml of 10 M NaOH. 10 M NaOH is also prepared freshly, by dissolving 20 g NaOH in 50 ml H 2 O. The solution of saturated sodium bisulphite is achieved by gently inverting the reagent/H 2 O mixture, with minimum mixing and aeration, and may require pH adjustment with 10 M NaOH before all is nearly dissolved. As it is saturated some small lumps may still remain undissolved. Use the freshly made solution either immediately or on the same day. If not used immediately store the solution in the dark or in foil after preparation. m CRITICAL STEP It is important that the bisulphite conversion reaction takes place in the dark to avoid oxidation, so if this is not possible, wrap the tubes in foil prior to incubation. After incubation, centrifuge briefly for 10 sec and remove and discard the mineral oil that is on the top phase. The mineral oil can be easily removed by freezing the tubes and since the oil does not freeze it can be pipetted from the bisulphite reaction. The mineral oil is required to prevent evaporation, however, it is not required if the reaction is performed in a PCR thermocycler with a heated lid. m CRITICAL STEP The two variables to consider in deciding on the length of bisulphite treatment are the quantity and quality of DNA to be converted. Recommended incubation times for limited amounts or poor quality, degraded DNA, such as that isolated from paraffin embedded tissue, is 4 h. DNA that is of high molecular weight, such as isolated from tissue culture cells, can be incubated for 4 h, if the concentration is less than 100 ng DNA; 6 h for 100 to 500 ng DNA; and 6-16 h for 500 ng to 2 mg DNA. Remove the supernatant into a clean 1.5 ml tube and dilute with 200 ml of H 2 O to reduce the salt concentration. Extract the supernatant twice with 400 ml of phenol:chloroform:isoamylalcohol mix and collect the upper aqueous phase. Add 900 ml of ice-cold ethanol to the aqueous phase and leave for 1 h or more at -20 1C. Centrifuge the solution at top speed for 10 min at 4 1C, then remove the supernatant and resuspend the pellet in 40 ml of H 2 O. After the DNA is dissolved, the concentration can be determined and the DNA should be frozen at -20 1C.
PROCEDURE
' PAUSE POINT The DNA can be stored for many years at -20 1C until required for bisulphite treatment.
DNA extraction from paraffin block samples: Trim the excess wax from cored tissue (5 mm punches) from the paraffin block. Place the core in a 1.5 ml tube and add 400 ml of 1Â Lysis buffer 2. Thoroughly homogenize the samples with disposable 1.5 ml pestles and incubate in 1.5 ml tubes for 48 h at 55 1C. After incubation, subject the samples to five freeze-thaw cycles in dry ice for 5 min, followed by 95 1C for 5 min. Vortex the samples and centrifuge at top speed for 2 min to pellet the cell debris. Remove the supernatant into a clean 1.5 ml tube and dilute with 200 ml of H 2 O to reduce the salt concentration. Extract the supernatant twice with 400 ml of phenol:chloroform mix. Add 900 ml of ice-cold ethanol and leave for 1 h or more at -20 1C. Centrifuge the solution at top speed for 10 min at 4 1C, then remove the supernatant and resuspend the pellet in 18 ml of H 2 O. After the DNA is dissolved, it can be frozen at -20 1C or used directly in the bisulphite reaction. ' PAUSE POINT The DNA can be stored for at least one year at -20 1C until required for bisulphite treatment. (B) 96 well reaction plate (i) Add the following to the denatured DNA sample in the 96 well plate immediately after the centrifugation.
Seal plate again, vortex and spin down briefly, and incubate at 55 1C for 6 h. m CRITICAL STEP As for the single tube reaction it is important to prepare the Saturated Sodium Metabisulfite at pH 5.0, freshly by dissolving 7.6 g Na 2 O 5 S 2 in 15 ml sterile H 2 O, and adding 464 ml of 10 M NaOH. 10 M NaOH is also prepared freshly, by dissolving 20 g NaOH in 50 ml H 2 O. The solution of saturated sodium bisulphite is achieved by gently inverting the reagent/H 2 O mixture, with minimum mixing and aeration, and may require pH adjustment before all is nearly dissolved. As it is saturated some small lumps may still remain undissolved. Use the freshly made solution on the same day and store in the dark or in foil after preparation. ' PAUSE POINT The bisulphite-treated DNA can be stored at -20 1C for 1-10 years, depending on the quality and quantity of the starting genomic DNA. m CRITICAL STEP Ensure that all traces of ethanol are removed as this can affect the PCR reaction. We recommend this clean-up protocol if the DNA is resuspended in lysis buffer prior to the bisulphite reaction, as an ethanol precipitation step is required to remove the SDS and proteinase K solution. Desalting by Wizard columns is simple and takes a minimum of 2 h to complete after the bisulphite reaction for a maximum of 24 tubes (24-well microfuge). See Figure 2 for further information. Denatured DNA (100 ng-2 mg) 10 ml Saturated sodium metabisulfite at pH 5.0 104 ml 10 mM Quinol 6 ml ' PAUSE POINT After the desalting and desulphonation steps, the bisulphite-treated DNA can be stored for 1-10 years at -20 1C, depending on the quality of the starting DNA. m CRITICAL STEP This procedure does not require an ethanol precipitation step, but is more labor-intensive and takes a minimum of 3 h to complete after the bisulphite reaction for 24 tubes. The length of time to ensure complete washing at each spin varies according to the centrifuge. We recommend this procedure if the DNA is resuspended in H 2 O or DNA buffer prior to the bisulphite reaction and/or if o500 ng of DNA is used in the bisulphite reaction, as there is less loss when no ethanol precipitation is required. However, if the bisulphite reaction contains lysis buffer, the size-exclusion clean-up protocol will concentrate factors that are inhibitory to PCR. Therefore, in this case, a subsequent ethanol precipitation step is required after elution. See Figure 2 for further information.
' PAUSE POINT The bisulphite-treated DNA can be stored, sealed, at -20 1C for 1-10 years. m CRITICAL STEP This procedure is more costly and labor-intensive and requires an ethanol precipitation step.
Bisulphite PCR amplification 4| To perform methylation bisulphite sequencing on a given target sequence, the bisulphite-treated DNA is amplified using PCR oligonucleotide primers that can amplify both methylated (M) and unmethylated (U) DNA in proportion. In a temperature-gradient thermocycler, set the run reaction in a gradient + and -3 1C from the predicted Tm of the primer across 10 tubes.
? TROUBLESHOOTING 7| To test that the methylated and unmethylated DNA have amplified in proportion, the amplicon can be digested with an informative restriction enzyme, such as Taq1 (TCGA), that will digest methylated DNA but will not digest unmethylated DNA when the restriction enzyme site is altered after bisulphite conversion to TTGA. The products can then be visualized for the extent of digestion after electrophoresis of the products on an agarose gel (Fig. 3a) . Alternatively, SYBRGreen (0.2 ml) (1:1,000 dilution) can be added to the PCR reaction and the extent of methylation can be assessed by performing heatdissociation plots in a real-time PCR thermocycler (Fig. 3b) .
? TROUBLESHOOTING Conversion-specific primers 8| The design of PCR bisulphite conversion-specific primers is crucial for ensuring that the efficient amplification of completely converted DNA occurs. The list of criteria given in Box 2 can be used to aid design. 
ANTICIPATED RESULTS
After bisulphite treatment, the DNA is amplified with strand-specific and bisulphite-specific primers in either a single or seminested PCR reaction. The resulting PCR fragments can be visualized by agarose-gel electrophoresis, as shown in Figure 2a and sequenced either directly (Fig. 4a) or by cloning and sequencing (Fig. 4b) . After cloning and sequencing, the methylation state of the individual molecules can be tabulated to visualize the heterogeneity of methylation (Fig. 4c) . Cloning and sequencing is still the only available method that can give single-nucleotide resolution for methylation across the DNA molecule. were bisulphite converted and amplified in triplicate with bisulphite-specific primers to the target region of interest. The pooled PCR products were purified using the Wizard PCR DNA purification system to remove any primer dimers before sequencing. (a) The PCR products were directly sequenced using the reverse primer of the PCR amplification in the Dye Terminator cycle sequencing kit with AmpliTaq DNA polymerase, and the automated 3730 DNA analyser with KB TM basecaller in Sequence analysis v5.1 (Applied Biosystems). Direct DNA sequencing through CpG sites 8-16 within the PCR fragment is shown. The degree of methylation at each CpG site from the direct sequencing profile was estimated by measuring the relative peak height of the cytosine (C) versus thymine (T) profile. As this can only be regarded as semi-quantitative, the degree of methylation was expressed as either 0%, 25%, 50%, 75% or 100%. (b) The pooled PCR products from the tumor sample were cloned into the pGEM R -T-Easy Vector (Promega) using the Rapid Ligation Buffer System (Promega). Eleven individual clones were sequenced from the PCR reactions using the Dye Terminator cycle sequencing kit with AmpliTaq DNA polymerase, FS (Applied Biosystems) and the automated 373A NA Sequencer (Applied Biosystems). Clonal DNA sequencing examples from five independent colonies, spanning CpG sites 8-16 within the PCR fragment, are shown. The '+' below the sequence indicates a methylated CpG and a '-' indicates an unmethylated CpG. (c) Summary of the DNA methylation data from tumour samples, based on clonal analysis of 11 clones from the pooled PCR fragments. Bisulphite sequencing of individual clones validated the semi-quantitative methylation levels obtained from direct PCR sequencing analysis, but the level of detail obtained from clonal analysis highlights the degree of methylation heterogeneity that is often observed in clinical samples and this detail is often lost using direct PCR sequencing. 
